Md. Code, Health-Gen. § 13-3501

Current with changes from the 2024 Legislative Session
Section 13-3501 - Definitions
(a) In this subtitle the following words have the meanings indicated.
(b) "Co-prescribing" means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose.
(c) "Opioid overdose reversal drug" means naloxone or a similarly acting and equally safe drug that is approved by the federal Food and Drug Administration for the treatment of a known or suspected opioid overdose.

Md. Code, HG § 13-3501

Added by 2017 Md. Laws, Ch. 572,Sec. 1, eff. 6/1/2017.
Added by 2017 Md. Laws, Ch. 571,Sec. 1, eff. 6/1/2017.